Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16201 | 667 | 50.5 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
363 | 2 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 17354 |
16201 | 1 | COMPLEMENT//BIIG//VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN | 667 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COMPLEMENT | authKW | 418873 | 32% | 4% | 215 |
2 | BIIG | address | 163493 | 1% | 71% | 5 |
3 | VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN | authKW | 137331 | 1% | 50% | 6 |
4 | BRAIN INFLAMMAT IMMUN GRP | address | 127374 | 1% | 35% | 8 |
5 | C1Q | authKW | 122559 | 4% | 9% | 29 |
6 | VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN VCP | authKW | 103001 | 0% | 75% | 3 |
7 | CD59 COMPLEMENT INHIBITOR | authKW | 91558 | 0% | 100% | 2 |
8 | NEUROIMMUNOL UNIT CMM L8 04 | address | 91558 | 0% | 100% | 2 |
9 | ANAPHYLATOXIN | authKW | 84349 | 3% | 9% | 20 |
10 | CHEMOTACTIC RECEPTOR | authKW | 81380 | 1% | 44% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 6961 | 59% | 0% | 392 |
2 | Immunology | 2779 | 32% | 0% | 211 |
3 | Clinical Neurology | 567 | 14% | 0% | 93 |
4 | Geriatrics & Gerontology | 477 | 5% | 0% | 32 |
5 | Pathology | 345 | 7% | 0% | 47 |
6 | Biochemistry & Molecular Biology | 69 | 13% | 0% | 87 |
7 | Medicine, Research & Experimental | 68 | 5% | 0% | 33 |
8 | Critical Care Medicine | 23 | 1% | 0% | 10 |
9 | Cell Biology | 15 | 5% | 0% | 31 |
10 | Allergy | 5 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIIG | 163493 | 1% | 71% | 5 |
2 | BRAIN INFLAMMAT IMMUN GRP | 127374 | 1% | 35% | 8 |
3 | NEUROIMMUNOL UNIT CMM L8 04 | 91558 | 0% | 100% | 2 |
4 | VALERIUSKLIN | 61037 | 0% | 67% | 2 |
5 | KINSMEN NEUROL | 49893 | 3% | 6% | 17 |
6 | BIOL EVALUAT BLOOD BLOOD PROD | 45779 | 0% | 100% | 1 |
7 | BRAIN INFLAMMAT IMMUN GRP BIIG | 45779 | 0% | 100% | 1 |
8 | CALIF MED NEUROL | 45779 | 0% | 100% | 1 |
9 | CLIN SCI MALMOWALLENBERG | 45779 | 0% | 100% | 1 |
10 | D VS N | 45779 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROINFLAMMATION | 27974 | 5% | 2% | 32 |
2 | JOURNAL OF NEUROIMMUNOLOGY | 11408 | 6% | 1% | 41 |
3 | NEUROBIOLOGY OF AGING | 4555 | 4% | 0% | 24 |
4 | MOLECULAR IMMUNOLOGY | 2842 | 3% | 0% | 21 |
5 | CINEFORUM | 1759 | 0% | 4% | 1 |
6 | GLIA | 1488 | 2% | 0% | 11 |
7 | EXPERIMENTAL NEUROLOGY | 1399 | 3% | 0% | 17 |
8 | CRITICAL REVIEWS IN ORAL BIOLOGY AND MEDICINE | 1385 | 0% | 3% | 1 |
9 | NEUROSCIENCE LETTERS | 1286 | 4% | 0% | 30 |
10 | CURRENT ALZHEIMER RESEARCH | 1201 | 1% | 1% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMPLEMENT | 418873 | 32% | 4% | 215 | Search COMPLEMENT | Search COMPLEMENT |
2 | VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN | 137331 | 1% | 50% | 6 | Search VACCINIA+VIRUS+COMPLEMENT+CONTROL+PROTEIN | Search VACCINIA+VIRUS+COMPLEMENT+CONTROL+PROTEIN |
3 | C1Q | 122559 | 4% | 9% | 29 | Search C1Q | Search C1Q |
4 | VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN VCP | 103001 | 0% | 75% | 3 | Search VACCINIA+VIRUS+COMPLEMENT+CONTROL+PROTEIN+VCP | Search VACCINIA+VIRUS+COMPLEMENT+CONTROL+PROTEIN+VCP |
5 | CD59 COMPLEMENT INHIBITOR | 91558 | 0% | 100% | 2 | Search CD59+COMPLEMENT+INHIBITOR | Search CD59+COMPLEMENT+INHIBITOR |
6 | ANAPHYLATOXIN | 84349 | 3% | 9% | 20 | Search ANAPHYLATOXIN | Search ANAPHYLATOXIN |
7 | CHEMOTACTIC RECEPTOR | 81380 | 1% | 44% | 4 | Search CHEMOTACTIC+RECEPTOR | Search CHEMOTACTIC+RECEPTOR |
8 | C3 | 78106 | 4% | 6% | 27 | Search C3 | Search C3 |
9 | C5B 9 | 73838 | 2% | 15% | 11 | Search C5B+9 | Search C5B+9 |
10 | COMPLEMENT SYSTEM | 71508 | 5% | 5% | 32 | Search COMPLEMENT+SYSTEM | Search COMPLEMENT+SYSTEM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRENNAN, FH , LEE, JD , RUITENBERG, MJ , WOODRUFF, TM , (2016) THERAPEUTIC TARGETING OF COMPLEMENT TO MODIFY DISEASE COURSE AND IMPROVE OUTCOMES IN NEUROLOGICAL CONDITIONS.SEMINARS IN IMMUNOLOGY. VOL. 28. ISSUE 3. P. 292 -308 | 100 | 54% | 0 |
2 | ORSINI, F , DE BLASIO, D , ZANGARI, R , ZANIER, ER , DE SIMONI, MG , (2014) VERSATILITY OF THE COMPLEMENT SYSTEM IN NEUROINFLAMMATION, NEURODEGENERATION AND BRAIN HOMEOSTASIS.FRONTIERS IN CELLULAR NEUROSCIENCE. VOL. 8. ISSUE . P. - | 89 | 53% | 22 |
3 | WOODRUFF, TM , AGER, RR , TENNER, AJ , NOAKES, PG , TAYLOR, SM , (2010) THE ROLE OF THE COMPLEMENT SYSTEM AND THE ACTIVATION FRAGMENT C5A IN THE CENTRAL NERVOUS SYSTEM.NEUROMOLECULAR MEDICINE. VOL. 12. ISSUE 2. P. 179 -192 | 87 | 62% | 36 |
4 | VEERHUIS, R , NIELSEN, HM , TENNER, AJ , (2011) COMPLEMENT IN THE BRAIN.MOLECULAR IMMUNOLOGY. VOL. 48. ISSUE 14. P. 1592 -1603 | 85 | 49% | 92 |
5 | BRENNAN, FH , ANDERSON, AJ , TAYLOR, SM , WOODRUFF, TM , RUITENBERG, MJ , (2012) COMPLEMENT ACTIVATION IN THE INJURED CENTRAL NERVOUS SYSTEM: ANOTHER DUAL-EDGED SWORD?.JOURNAL OF NEUROINFLAMMATION. VOL. 9. ISSUE . P. - | 79 | 56% | 40 |
6 | ALAWIEH, A , ELVINGTON, A , TOMLINSON, S , (2015) COMPLEMENT IN THE HOMEOSTATIC AND ISCHEMIC BRAIN.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. 1 -18 | 73 | 59% | 5 |
7 | RUS, H , CUDRICI, C , DAVID, S , NICULESCU, F , (2006) THE COMPLEMENT SYSTEM IN CENTRAL NERVOUS SYSTEM DISEASES.AUTOIMMUNITY. VOL. 39. ISSUE 5. P. 395-402 | 61 | 79% | 33 |
8 | GASQUE, P , DEAN, YD , MCGREAL, EP , VANBEEK, J , MORGAN, BP , (2000) COMPLEMENT COMPONENTS OF THE INNATE IMMUNE SYSTEM IN HEALTH AND DISEASE IN THE CNS.IMMUNOPHARMACOLOGY. VOL. 49. ISSUE 1-2. P. 171-186 | 69 | 68% | 219 |
9 | VEERHUIS, R , (2011) HISTOLOGICAL AND DIRECT EVIDENCE FOR THE ROLE OF COMPLEMENT IN THE NEUROINFLAMMATION OF AD.CURRENT ALZHEIMER RESEARCH. VOL. 8. ISSUE 1. P. 34 -58 | 94 | 41% | 32 |
10 | GASQUE, P , NEAL, JW , SINGHRAO, SK , MCGREAL, EP , DEAN, YD , VAN BEEK, J , MORGAN, BP , (2002) ROLES OF THE COMPLEMENT SYSTEM IN HUMAN NEURODEGENERATIVE DISORDERS - PRO-INFLAMMATORY AND TISSUE REMODELING ACTIVITIES.MOLECULAR NEUROBIOLOGY. VOL. 25. ISSUE 1. P. 1-17 | 68 | 71% | 44 |
Classes with closest relation at Level 1 |